ArticleClinical pharmacology in drug development2021

A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.

Ching Thai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.